Rexahn Pharmaceuticals, Inc. (NYSE: RNN) announced the appointment of Lisa Nolan, Ph.D., to the newly-created position of Chief Business Officer ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE